US Patent Issued to FIREBRICK PHARMA on Feb. 15 for "Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes" (Australian Inventors).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    Australian Government. 2022.